News

“Phenylephrine is an oral decongestant and vasoconstrictor ... that it will hopefully clear up some sinus issues.” The FDA has proposed to remove oral phenylephrine, saying citing evidence ...
(The Hill) — The Food and Drug Administration (FDA) is proposing the removal from the market of ... phenylephrine is not effective as a nasal decongestant when taken in liquid or pill form ...
A federal judge has upheld the FDA’s decision to remove Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro from the national drug shortage list, Reuters reported May 7.
The FDA issued a public alert on Tuesday concerning generic versions of a widely-used hair loss drug that is frequently distributed by popular telehealth brands like Hims and Keeps. The agency ...
May 7 (Reuters) - A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s (LLY.N), opens new tab blockbuster weight loss and diabetes drugs Zepbound and ...
Makary emphasized the need to prioritize children’s safety. The FDA has set a goal to complete a safety review and public comment period, and take appropriate action regarding the removal of these ...